ArticleFrontiers in pharmacology2026

AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic ductal adenocarcinoma spheroids and organoids.

Emma Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.